Analytical Data
-
基因名
GDAP1L1
- Application
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96MZ0
-
表达区间
1-367aa
-
氨基酸序列
MATPNNLTPT NCSWWPISAL ESDAAKPAEA PDAPEAASPA HWPRESLVLY HWTQSFSSQK VRLVIAEKGL VCEERDVSLP QSEHKEPWFM RLNLGEEVPV IIHRDNIISD YDQIIDYVER TFTGEHVVAL MPEVGSLQHA RVLQYRELLD ALPMDAYTHG CILHPELTTD SMIPKYATAE IRRHLANATT DLMKLDHEEE PQLSEPYLSK QKKLMAKILE HDDVSYLKKI LGELAMVLDQ IEAELEKRKL ENEGQKCELW LCGCAFTLAD VLLGATLHRL KFLGLSKKYW EDGSRPNLQS FFERVQRRFA FRKVLGDIHT TLLSAVIPNA FRLVKRKPPS FFGASFLMGS LGGMGYFAYW YLKKKYI
-
分子量
68.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GDAP1L1 (Ganglioside-induced differentiation-associated protein 1-like 1) is a member of the GDAP gene family, which is implicated in the differentiation and maintenance of neural cells, particularly in the context of neurological disorders. The protein is believed to play a significant role in mitochondrial dynamics and cell stress responses, suggesting its potential involvement in neurodegenerative diseases and metabolic disorders. Recent studies have highlighted that mutations in GDAP1L1 are linked to various hereditary neuropathies, pointing to its critical function in peripheral nervous system development. The exploration of GDAP1L1 as a recombinant protein is essential for understanding its biological functions at the molecular level, creating opportunities for therapeutic interventions. Investigating GDAP1L1 through recombinant protein expression can illuminate its interactions with other cellular components, elucidate its role in mitochondrial function, and provide insights into the pathways affected by its dysregulation. Furthermore, utilizing this protein as a tool for drug screening or gene therapy may open new avenues for treating conditions associated with GDAP1L1 dysfunction. Thus, the study of GDAP1L1's recombinant protein is of considerable interest within the fields of molecular biology, genetics, and therapeutic development, aiming to bridge the gap between basic research and clinical applications in neurology.
